Targeting Immunomodulatory Effects of Donor Extracellular Vesicles to Decrease Rejection after Liver Transplant with Dr. David Al-Adra
VANGUARD TRANSPLANT ROUNDS
Transplant Innovation Centre | 9 MaRS West Tower Conference Room 9006*
*Access to the 9th floor of the MaRS West Tower is exclusively for ATC staff with badge-access privileges only.
A virtual option available for all others: https://utoronto.zoom.us/j/85284226951
Learning Objectives:
1. Recognize mechanisms of liver rejection after transplantation
2. Define the immunological roles of EVs
3. Understand how EVs from different donors may influence liver rejection
Speaker Biography:
Dr. Al-Adra is an Assistant Professor of Surgery at the University of Wisconsin. He joined the faculty at UW in 2017 after completing his fellowship in Abdominal Transplant Surgery in Toronto. He specializes in liver and kidney transplantation and hepatobiliary surgery. He has a special interest in living donor kidney and liver transplantation and is the surgical director of the living donor liver transplant program. Dr. Al-Adra’s basic science research involves uncovering the mediators behind organ rejection after transplantation. In his presentation today, he will discuss liver-derived extracellular vesicles and their role in liver rejection and how these vesicles may be modified to decrease rejection after liver transplantation.
Transplant Grand Rounds is an approved group learning activity (Section 1) as defined by the Maintenance of Certification (MOC) program of the Royal College of Physicians and Surgeons of Canada.